Shuang Li
Director/Board Member bij YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Vermogen: 92 863 $ op 31-03-2024
Profiel
Shuang Li is currently working as an Executive Director & Deputy General Manager at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
since 2018.
Additionally, Mr. Li is also working as a Director at HEC Pharm Co., Ltd.
Mr. Li completed their undergraduate degree from China Three Gorges University in 2004.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 66 800 ( 0.01% ) | 92 863 $ | 31-03-2024 |
Actieve functies van Shuang Li
| Bedrijven | Functie | Begin |
|---|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Director/Board Member | 08-06-2018 |
HEC Pharm Co., Ltd.
 HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Director/Board Member | - |
Opleiding van Shuang Li
| China Three Gorges University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
HEC Pharm Co., Ltd.
HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Health Technology |
